Network & Partners

Medical Advisory Board

The Medical Advisory Board consists of Professor Kathryn Wood, Professor Christophe Legendre, Professor Stanley Jordan and Professor Robert A. Montgomery.
These distinguished experts bring invaluable medical expertise on kidney transplantation and desensitization to Hansa Biopharma.

 

Prof. Stanley Jordan

Director of Kidney Transplantation and Transplant Immunology. Director of Division of Pediatric and Adult Nephrology at CSMC

Prof. Stanley Jordan (Chairman), MD, PhD, is a Director of Kidney Transplantation and Transplant Immunology, Kidney and Pancreas Transplant Center and Director of Division of Pediatric and Adult Nephrology at Cedars Sinai Medical Center, Los Angeles, USA. Professor Jordan's focus is on immunology and transplantation. He has performed extensive research funded by dozens of research grants and awards, including National Institutes of Health controlled clinical trials in kidney transplantation. Professor Jordan has written hundreds of articles in scientific journals and authored about two dozen book chapters. He was appointed by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to advise Congress on the safety and efficacy of intravenous gammaglobulin products. Professor Jordan has been principal investigator on three NIH Controlled Clinical Trials in Kidney Transplantation. Professor Jordan has received the Medical Sciences Award from the UCLA Alumni Association, Gift of Life Award from the National Kidney Foundation, Established Investigator Award from the American Society of Transplantation and Distinguished Alumni Award from the University of North Carolina-Chapel Hill School of Medicine. Professor Jordan is a member of national and international professional societies and has served on the editorial boards of numerous professional journals.

Read more Read less

Prof. Robert A. Montgomery

Director at NYU Langone Transplant Institute

Prof. Robert A. Montgomery, MD, DPhil, FACS is Director at NYU Langone Transplant Institute, New York, NY, USA. Professor Robert A. Montgomery is the inaugural recipient of the Margery K. and Thomas Pozefsky Endowed Professorship in Kidney Transplantation. Professor Montgomery was part of the team that developed the laparoscopic procedure for live kidney donation, a procedure that has become the standard throughout the world. Professor Montgomery is considered a world expert on kidney transplantation for highly sensitized and ABO incompatible patients. Professor Montgomery has received important awards and distinctions including a Fulbright Scholarship, a Thomas J. Watson Fellowship and memberships in the Phi Beta Kappa and Alpha Omega Alpha academic honor societies. He has been awarded multiple scholarships from The American College of Surgeons and The American Society of Transplant Surgeons. The National Kidney Foundation of Maryland has recognized his contributions to the field of transplantation with the Champion of Hope Award and the National Kidney Registry recognized him with the Terasaki Medical Innovation Award.

Read more Read less

Prof. Christophe Legendre

Professor of Nephrology, Paris Descartes University

Prof. Christophe Legendre, MD, PhD is Professor of Nephrology at the Paris Descartes University and Head of the Adult Nephrology and Transplantation unit at Necker Hospital in Paris. Prof. Legendre’s main research interests include the clinical evaluation of new immunosuppressants, viral infection after transplantation, transplantation in high-risk recipients, screening kidney biopsies and recurrence of disease post transplantation. He has published around 340 papers in English peer reviewed journals. Prof. Legendre is member of several professional societies including the American Society of Transplantation, the European Society for Organ Transplantation and the Transplantation Society as well as associate editor of the American Journal of Transplantation and Europe Regional Associate Editor of the journal Transplantation.

Read more Read less

Prof. Kathryn Wood

Professor of Immunology at University of Oxford

Prof. Kathryn Wood, PhD, is Professor of Immunology in the Nuffield Department of Surgical Sciences, University of Oxford where she runs the Transplantation Research Immunology Group. Prof. Wood is an internationally renowned medical researcher in transplant tolerance induction, immune regulation and interaction between the immune system and stem cell derived tissues. She is a Fellow of The Academy of Medical Sciences and has received several international awards for her distinguished research, including the Royal Society Wolfson Merit Award for research excellence. Prof. Wood has served as President of the Transplantation Society and currently leads the Women in Transplantation Initiative and functions as editor of the journal Transplantation.

Read more Read less
left-photo-mask

Partnering

Hansa is developing imlifidase, an antibody cleaving enzyme, as a proprietary treatment to enable kidney transplantation in highly sensitized patients. We are also investigating the effect of the enzyme in life threatening acute autoimmune diseases within neurology, nephrology and haematology.

Innovation & Focus

We believe imlifidase has potential applications as pre-treatment and combination therapy in immune oncology and gene therapy. Hansa seeks strategic collaborations anchored in our technology platform but outside our core therapeutic areas, transplant and autoimmunity. We select our partners carefully based on therapeutic expertise and a significant commitment to development and commercialization of biopharmaceuticals.

In our partnership with Axis-Shields Diagnostics, a subsidiary to Abbott, we have out-licensed the HBP-assay. Axis-Shield is engaged in further product development and clinical development with the HBP-assay. Hansa holds the right to royalty payments from Axis-Shield.

If you would like to get in touch with our Business Development professionals, please send us an e-mail at bd@hansabiopharma.com

Collaborations

We partner with scientific, medical and patient communities around the world to create sustainable value for rare patients, shareholders, and societies.

NYU Langone Medical Center
Necker
Lund University
Cedars-Sinai: A Non-Profit Hospital in Los Angeles
Uppsala University Sweden
John Hopkins University
The University of Oxford